Search Results - "Goldenheim, P"

Can a Controlled-Release Oral Dose Form of Oxycodone Be Used as Readily as an Immediate-Release Form for the Purpose of Titrating to Stable Pain Control? by Salzman, Robert T., Roberts, Michael S., Wild, James, Fabian, Carol, Reder, Robert F., Goldenheim, Paul D.

“…Two separate trials compared controlled-release (CR) oral oxycodone (administered every 12 hours) with immediate-release (IR) oxycodone (4 times a day) to…”
Get full text

Pharmacokinetic-pharmacodynamic relationships of controlled-release oxycodone by Kaiko, R F, Benziger, D P, Fitzmartin, R D, Burke, B E, Reder, R F, Goldenheim, P D

“…Plasma concentrations of oxycodone, oxymorphone, and noroxycodone were determined after administration of 20 mg oral controlled-release oxycodone tablets to…”
Get more information

An appraisal of povidone-iodine and wound healing by Goldenheim, P D

“…Infection is one of the most frequent complications of wound healing despite the use of antibiotics and modern sterile technique; it accounts for considerable…”
Get full text

Analgesic efficacy of controlled-release oxycodone in postoperative pain by Sunshine, A, Olson, N Z, Colon, A, Rivera, J, Kaiko, R F, Fitzmartin, R D, Reder, R F, Goldenheim, P D

“…The efficacy and safety of graded doses (10, 20, and 30 mg) of controlled-release (CR) oxycodone was compared with that of immediate-release (IR) oxycodone (15…”
Get more information

In vitro efficacy of povidone-iodine solution and cream against methicillin-resistant Staphylococcus aureus by Goldenheim, P D

“…Methicillin-resistant Staphylococcus aureus (MRSA) has emerged worldwide as a significant and difficult-to-treat source of nosocomial infection, emphasizing…”
Get full text

Methylxanthines by Goldenheim, P

Get more information

Prediction and reversal of blunted ventilatory responsiveness in patients with hypothyroidism by Ladenson, P W, Goldenheim, P D, Ridgway, E C

“…To define the prevalence of impaired ventilatory responses in hypothyroidism, clinical and chemical parameters predicting their presence, and the potential for…”
Get more information

The bioavailability of morphine in controlled-release 30-mg tablets per rectum compared with immediate-release 30-mg rectal suppositories and controlled-release 30-mg oral tablets by Kaiko, R F, Fitzmartin, R D, Thomas, G B, Goldenheim, P D

“…The bioavailability of controlled-release morphine 30-mg tablets (MSC) administered orally or rectally and immediate-release morphine (RMS) 30-mg suppositories…”
Get more information

Relative bioavailability of controlled-release oral morphine sulfate during naltrexone blockade by Bashaw, E D, Kaiko, R F, Grandy, R P, Reder, R F, Goldenheim, P D

“…The effect of naltrexone hydrochloride on the bioavailability of 60 mg controlled-release oral morphine sulfate in normal volunteers was determined using a…”
Get more information

A bioequivalence study of oral controlled-release morphine using naltrexone blockade by Kaiko, R F, Grandy, R P, Reder, R F, Goldenheim, P D, Sackler, R S

“…Twenty-three normal volunteers who received morphine sulphate (MS Contin) with naltrexone completed this randomized, analytically blinded, two-way crossover…”
Get more information

Steady-state pharmacokinetics of controlled release oral morphine sulphate in healthy subjects by SAVARESE, J. J, GOLDENHEIM, P. D, THOMAS, G. A, KAIKO, R. F

“…The pharmacokinetics of oral morphine sulphate as controlled release tablets ('MS-Contin') and solution were compared at steady-state. Plasma morphine…”
Get full text

Pulmonary function in normal subjects and patients with sarcoidosis after bronchoalveolar lavage by Tilles, D S, Goldenheim, P D, Ginns, L C, Hales, C A

“…To determine if fiberoptic bronchoscopy (FOB) with bronchoalveolar lavage impairs pulmonary function in normal subjects or those with sarcoidosis, we measured…”
Get more information

Incidence and clinical correlates of nocturnal awakening secondary to dyspnea in chronic obstructive airway disease (COAD) by Braun, S R, Lee, B R, Conrad, E A, Scott, G C, Goldenheim, P D

Get more information

Once-daily evening administration of Uniphyl tablets: announcement of first available chronotherapy of nocturnal asthma by Goldenheim, P D

Get more information

Analgesic efficacy and safety of two oral controlled-release morphine preparations in orthopedic postoperative pain by Cooper, S A, Fitzmartin, R, Slywka, J, Buckley, B J, Kaiko, R, Goldenheim, P D, Mooar, P, Witte, J F, Hersh, E V

“…This single-dose, double-blind, randomized, parallel-group study compared the analgesic efficacy and safety of MS Contin (MSC) and Oramorph SR (OSR), two…”
Get more information

Evaluation of a cancer pain model for the testing of long-acting analgesics. The effect of MS Contin in a double-blind, randomized crossover design by Cundiff, D, McCarthy, K, Savarese, J J, Kaiko, R, Thomas, G, Grandy, R, Goldenheim, P

“…A double-blind, double-dummy, crossover study compared oral controlled-release morphine sulfate (MS Contin tablets [MSC], Purdue Frederick, Norwalk, CT) every…”
Get more information

Asthma therapy and airway inflammation by Goldenheim, P D

Get more information

Analgesic efficacy and potency of two oral controlled-release morphine preparations by Bloomfield, S S, Cissell, G B, Mitchell, J, Barden, T P, Kaiko, R F, Fitzmartin, R D, Grandy, R P, Komorowski, J, Goldenheim, P D

“…MS Contin tablets and Oramorph SR tablets are two forms of oral controlled-release morphine sulfate available for the alleviation of pain. Our objective was to…”
Get more information

Intraperitoneal povidone-iodine by Goldenheim, P D

Get full text

Noninvasive testing of asymptomatic bilateral hilar adenopathy by Carr, P L, Singer, D E, Goldenheim, P, Bernardo, J, Mulley, A G

“…The diagnostic strategy for asymptomatic patients with persistent bilateral bilar adenopathy often involves invasive procedures. The authors used Bayesian…”
Get full text